AstraZeneca (AZN)

Add to Watchlists
Create an Alert
70.03 +0.26  +0.37% NYSE Mar 27, 3:11PM BATS Real time Currency in USD

AstraZeneca Cash from Investing (TTM):

-7.032B for Dec. 31, 2014

View 4,000+ financial data types

View Full Chart

AstraZeneca Cash from Investing (TTM) Chart

Export Data
Save Image

AstraZeneca Historical Cash from Investing (TTM) Data

View and export this data going back to 1993. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2014 -7.032B
Sept. 30, 2014 -6.52B
June 30, 2014 -6.606B
March 31, 2014 -6.302B
Dec. 31, 2013 -2.889B
Sept. 30, 2013 -2.399B
June 30, 2013 -4.45B
March 31, 2013 -2.816B
Dec. 31, 2012 -1.859B
Sept. 30, 2012 -4.925B
June 30, 2012 -955.00M
March 31, 2012 -1.529B
Dec. 31, 2011 -2.022B
Sept. 30, 2011 1.106B
June 30, 2011 92.00M
March 31, 2011 -1.019B
Dec. 31, 2010 -2.226B
Sept. 30, 2010 -3.678B
June 30, 2010 -4.346B
March 31, 2010 -3.657B
Dec. 31, 2009 -2.476B
Sept. 30, 2009 -1.044B
June 30, 2009 -859.00M
March 31, 2009 -885.00M
Dec. 31, 2008 -3.896B
   
Sept. 30, 2008 -3.851B
June 30, 2008 -3.593B
March 31, 2008 -17.21B
Dec. 31, 2007 -14.89B
Sept. 30, 2007 -14.18B
June 30, 2007 -14.75B
March 31, 2007 1.015B
Dec. 31, 2006 -272.00M
Sept. 30, 2006 -1.118B
June 30, 2006 -1.67B
March 31, 2006 -3.056B
Dec. 31, 2005 -1.182B
Sept. 30, 2005 1.043B
June 30, 2005 1.525B
March 31, 2005 1.237B
Dec. 31, 2004 970.00M
Sept. 30, 2004 -624.00M
June 30, 2004 -337.00M
March 31, 2004 -818.00M
Dec. 31, 2003 -852.00M
Sept. 30, 2003 -1.431B
June 30, 2003 -1.503B
March 31, 2003 -1.588B
Dec. 31, 2002 -1.543B
Sept. 30, 2002 -1.587B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Get data for
Advertisement

AZN Cash from Investing (TTM) Benchmarks

Companies
Bristol-Myers Squibb 1.216B
GlaxoSmithKline -1.776B
Johnson & Johnson -12.30B

AZN Cash from Investing (TTM) Range, Past 5 Years

Minimum -7.032B Dec 2014
Maximum 1.106B Sep 2011
Average -3.202B

AZN Cash from Investing (TTM) Excel Add-In Codes

  • Metric Code: cash_investing_ttm
  • Latest data point: =YCP("AZN", "cash_investing_ttm")
  • Last 5 data points: =YCS("AZN", "cash_investing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.